Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | MALT1 | Q9UDY8 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 2/20 | 0.47 |
| ▸ | RAB9A | P51151 | 2/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | SSTR2 | P30874 | 1/20 | 0.45 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21531020 | 0.97 | KDM4E (0.58) | KDM4EALDH1A1ALOX15POLBMALT1 | |
| SCHEMBL21531034 | 0.90 | CYP1A2 (0.57) | KDM4EALDH1A1ALOX15POLBMALT1 | |
| SCHEMBL30074568 | 0.84 | ALOX15 (0.54) | KDM4EALOX15POLBMALT1NPC1 | |
| SCHEMBL30074604 | 0.84 | ALOX15 (0.54) | KDM4EALDH1A1ALOX15POLBMALT1 | |
| SCHEMBL30074637 | 0.84 | ALOX15 (0.54) | KDM4EALDH1A1ALOX15POLBMALT1 | |
| SCHEMBL21531037 | 0.84 | ALOX15 (0.54) | KDM4EALOX15POLBMALT1NPC1 | |
| SCHEMBL27106687 | 0.83 | MEN1 (0.50) | KDM4EALDH1A1POLBNPC1RAB9A | |
| SCHEMBL20460424 | 0.83 | KMT2A (0.52) | KDM4EALDH1A1POLBNPC1RAB9A | |
| SCHEMBL30074585 | 0.83 | ALOX15 (0.53) | KDM4EALDH1A1ALOX15POLBMALT1 | |
| SCHEMBL30074623 | 0.83 | ALOX15 (0.53) | KDM4EALDH1A1ALOX15POLBMALT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11504439-B2 | Radioactive compound for diagnosis of malignant melanoma and use thereof | INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY (KR) | 2022-11-22 | — | — | US | disclosed |
| EP-3569589-A1 | RADIOACTIVE COMPOUND FOR DIAGNOSIS OF MALIGNANT MELANOMA AND USE THEREOF | Industry Foundation of Chonnam National University (KR) | 2019-11-20 | — | — | EP | disclosed |
| US-20190336621-A1 | RADIOACTIVE COMPOUND FOR DIAGNOSIS OF MALIGNANT MELANOMA AND USE THEREOF | INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY (KR) | 2019-11-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190336621-A1 | RADIOACTIVE COMPOUND FOR DIAGNOSIS OF MALIGNANT MELANOMA AND USE THEREOF | MITF, BRAF, MEN1 | KDM4E 767/4885ALDH1A1 1207/4885ALOX15 3399/4885 |
| US-11504439-B2 | Radioactive compound for diagnosis of malignant melanoma and use thereof | MITF, BRAF, MEN1 | KDM4E 767/4885ALDH1A1 1207/4885ALOX15 3399/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.